Highland Capital Management Fund Advisors, L.P. Imago Bio Sciences, Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $4.71 Million - $11.3 Million	313,477 New	313,477 $11.3 Million

Others Institutions Holding IMGO

# of Institutions

Shares Held

19.3K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

19.3K
Shares

$0
1.1% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Imago BioSciences, Inc.

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

More about IMGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account